Amicus Therapeutics Inc (NASDAQ:FOLD)
| 9.61 Delayed Data As of May 06 |  +0.01 / +0.10%Today’s Change | 8.83 Today|||52-Week Range 25.39 | -58.40% Year-to-Date |
Latest FOLD News | Press Releases
| Amicus Therapeutics Stock Gives Every Indication Of Being Possible Value Trap May 05 / GuruFocus News - Paid Partner Content | Amicus Therapeutics (FOLD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release May 03 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.59 |
| Today’s open | 9.67 |
| Day’s range | 9.44 - 9.73 |
| Volume | 2,324,427 |
| Average volume (3 months) | 3,599,879 |
| Market cap | $2.6B |
Data as of 3:59pm ET, 05/06/2021
Growth & Valuation
| Earnings growth (last year) | +27.85% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -85.64% |
| Revenue growth (last year) | +43.16% |
| P/E ratio | NM |
| Price/Sales | 22.91 |
| Price/Book | 9.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CORTCorcept Therapeutics... | +0.05 | +0.23% |
| VCELVericel Corp | -3.49 | -6.17% |
| GBTGlobal Blood Therape... | -1.60 | -4.02% |
| ITCIIntra-Cellular Thera... | +1.05 | +3.24% |
Data as of 4:10pm ET, 05/06/2021
Financials
| Next reporting date | May 10, 2021 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $260.9M |
| Annual profit (last year) | -$276.9M |
| Net profit margin | -106.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Philadelphia, Pennsylvania |
Forecasts
